newsfilter
← Latest News
PR Newswire·

Theseus Pharmaceuticals to Participate Virtually in SVB Leerink Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 9, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization